Page last updated: 2024-10-25

deferiprone and Central Nervous System Toxoplasmosis

deferiprone has been researched along with Central Nervous System Toxoplasmosis in 1 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Research Excerpts

ExcerptRelevanceReference
"The role of iron in cerebral toxoplasmosis (CT) is still unclear."1.91Iron-overload-induced ferroptosis in mouse cerebral toxoplasmosis promotes brain injury and could be inhibited by Deferiprone. ( Cai, Y; Gao, N; Liu, M; Wang, C; Xie, L; Xing, Y; Yang, J, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, C1
Xie, L1
Xing, Y1
Liu, M1
Yang, J1
Gao, N1
Cai, Y1

Other Studies

1 other study available for deferiprone and Central Nervous System Toxoplasmosis

ArticleYear
Iron-overload-induced ferroptosis in mouse cerebral toxoplasmosis promotes brain injury and could be inhibited by Deferiprone.
    PLoS neglected tropical diseases, 2023, Volume: 17, Issue:8

    Topics: Animals; Brain Injuries; Deferiprone; Ferroptosis; Iron; Mice; Toxoplasmosis, Cerebral

2023